» Articles » PMID: 22915524

In Vitro Analysis of the Cytotoxic and Anti-inflammatory Effects of Antioxidant Compounds Used As Additives in Ultra High-molecular Weight Polyethylene in Total Joint Replacement Components

Overview
Date 2012 Aug 24
PMID 22915524
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Ultra high-molecular weight polyethylene (UHMWPE) remains the most commonly used material in modern joint replacement prostheses. However, UHMWPE wear particles, formed as the bearing articulates, are one of the main factors leading to joint replacement failure via the induction of osteolysis and subsequent aseptic loosening. Previous studies have shown that the addition of antioxidants such as vitamin E to UHMWPE can improve wear resistance of the polymer and reduce oxidative fatigue. However, little is known regarding the biological consequences of such antioxidant chemicals. This study investigated the cytotoxic and anti-inflammatory effects of a variety of antioxidant compounds currently being tested experimentally for use in hip and knee prostheses, including nitroxides, hindered phenols, and lanthanides on U937 human histocyte cells and human peripheral blood mononuclear cells (PBMNCs) in vitro. After addition of the compounds, cell viability was determined by dose response cytotoxicity studies. Anti-inflammatory effects were determined by quantitation of TNF-α release in lipopolysaccharide (LPS)-stimulated cells. This study has shown that many of these compounds were cytotoxic to U937 cells and PBMNCs, at relatively low concentrations (micromolar), specifically the hindered phenol 3,5-di-tert-butyl-4-hydroxyhydrocinnamate (HPAO1), and the nitroxide 2,2,6,6-Tetramethylpiperidine 1-oxyl (TEMPO). Lanthanides were only cytotoxic at very high concentrations and were well tolerated by the cells at lower concentrations. Cytotoxic compounds also showed reduced anti-inflammatory effects, particularly in PBMNCs. Careful consideration should therefore be given to the use of any of these compounds as potential additives to UHMWPE.

Citing Articles

Current Knowledge on Biomaterials for Orthopedic Applications Modified to Reduce Bacterial Adhesive Ability.

Allizond V, Comini S, Cuffini A, Banche G Antibiotics (Basel). 2022; 11(4).

PMID: 35453280 PMC: 9024841. DOI: 10.3390/antibiotics11040529.


Macrophage inhibits the osteogenesis of fibroblasts in ultrahigh molecular weight polyethylene (UHMWPE) wear particle-induced osteolysis.

Lei P, Dai Z, Zhang Y, Liu H, Niu W, Li K J Orthop Surg Res. 2019; 14(1):80.

PMID: 30885228 PMC: 6421644. DOI: 10.1186/s13018-019-1119-8.


Do crosslinking and vitamin E stabilization influence microbial adhesions on UHMWPE-based biomaterials?.

Banche G, Bracco P, Allizond V, Bistolfi A, Boffano M, Cimino A Clin Orthop Relat Res. 2014; 473(3):974-86.

PMID: 25367109 PMC: 4317464. DOI: 10.1007/s11999-014-4024-9.


Future bearing surfaces in total hip arthroplasty.

Chang J Clin Orthop Surg. 2014; 6(1):110-6.

PMID: 24605198 PMC: 3942597. DOI: 10.4055/cios.2014.6.1.110.

References
1.
Oral E, Wannomae K, Hawkins N, Harris W, Muratoglu O . Alpha-tocopherol-doped irradiated UHMWPE for high fatigue resistance and low wear. Biomaterials. 2004; 25(24):5515-22. DOI: 10.1016/j.biomaterials.2003.12.048. View

2.
Oral E, Beckos C, Malhi A, Muratoglu O . The effects of high dose irradiation on the cross-linking of vitamin E-blended ultrahigh molecular weight polyethylene. Biomaterials. 2008; 29(26):3557-60. PMC: 2516939. DOI: 10.1016/j.biomaterials.2008.05.004. View

3.
Oral E, Ghali B, Muratoglu O . The elimination of free radicals in irradiated UHMWPEs with and without vitamin E stabilization by annealing under pressure. J Biomed Mater Res B Appl Biomater. 2011; 97(1):167-74. PMC: 3747829. DOI: 10.1002/jbm.b.31799. View

4.
Palasz A, Czekaj P . Toxicological and cytophysiological aspects of lanthanides action. Acta Biochim Pol. 2002; 47(4):1107-14. View

5.
Blunn G, Brach del Preva E, Costa L, Fisher J, Freeman M . Ultra high molecular-weight polyethylene (UHMWPE) in total knee replacement: fabrication, sterilisation and wear. J Bone Joint Surg Br. 2002; 84(7):946-9. DOI: 10.1302/0301-620x.84b7.13647. View